Jacob Glanville

Title: **Inventor Jacob Glanville: Pioneering Innovations in Immunotherapy**

Introduction

Jacob Glanville, an innovative inventor based in San Francisco, CA, has made significant contributions to the field of immunotherapy. With a remarkable portfolio of 17 patents, he has been at the forefront of developing advanced therapeutic solutions aimed at enhancing immune responses and treating various diseases.

Latest Patents

Among his latest groundbreaking patents is an invention focused on "Epitope focusing by variable effective antigen surface concentration." This patent outlines a multi-step process that generates antibodies or immunogenic compositions, such as vaccines, through careful selection and formulation of antigens. The process involves bioinformatics design steps, extensive in vitro testing, and the administration of the resulting immunogenic composition to enhance immune responses in host animals or patients. Another notable patent is the "MAdCAM targeted immunotolerance," which details methods for achieving site-specific immune privilege by targeting cells expressing MAdCAM, potentially offering novel solutions in the treatment of autoimmune diseases.

Career Highlights

Jacob has flourished in his career, playing crucial roles in companies such as Centivax, Inc. and Distributed Bio, Inc. His work has not only advanced scientific understanding but has also translated into practical applications aimed at improving patient care and treatment outcomes.

Collaborations

Throughout his career, Jacob has collaborated with esteemed colleagues, including Shahrad Daraeikia and I-Chieh Wang. These partnerships have enabled the pooling of expertise and resources, further enhancing the quality and impact of his inventions in the field of immunology.

Conclusion

Jacob Glanville continues to be a driving force in immunotherapy innovation. His patents reflect a deep understanding of the immune system and a commitment to developing effective treatments that could change the landscape of modern medicine. As research in this area evolves, Jacob's contributions are sure to have lasting implications for healthcare and therapeutic strategies.